Skip to main content
. 2021 Mar 3;16(1):367–374. doi: 10.1515/med-2021-0225

Figure 3.

Figure 3

The treatment and outcomes of hypertensive patients with COVID-19. (a) Antihypertensive used in hypertensive patients with COVID-19. (b) General treatment used in hypertensive patients with COVID-19. (c) The outcomes of hypertensive patients with COVID-19. a P values indicate differences between the mild and severe hypertensive patients. P < 0.05 was considered statistically significant.